Max Nieuwdorp
#148,063
Most Influential Person Now
Researcher
Max Nieuwdorp's AcademicInfluence.com Rankings
Max Nieuwdorpbiology Degrees
Biology
#10872
World Rank
#14232
Historical Rank
Microbiology
#608
World Rank
#676
Historical Rank
Immunology
#688
World Rank
#710
Historical Rank
Download Badge
Biology
Max Nieuwdorp's Degrees
- PhD Biomedical Sciences University of Amsterdam
- Masters Biomedical Sciences University of Amsterdam
- Bachelors Biomedical Sciences University of Amsterdam
Why Is Max Nieuwdorp Influential?
(Suggest an Edit or Addition)Max Nieuwdorp's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Duodenal infusion of donor feces for recurrent Clostridium difficile. (2013) (3035)
- Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. (2012) (2269)
- European consensus conference on faecal microbiota transplantation in clinical practice (2017) (705)
- Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. (2017) (580)
- Therapeutic potential of fecal microbiota transplantation. (2013) (515)
- Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. (2006) (499)
- Insights Into the Role of the Microbiome in Obesity and Type 2 Diabetes (2014) (488)
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. (2014) (450)
- Durable coexistence of donor and recipient strains after fecal microbiota transplantation (2016) (414)
- Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. (2006) (402)
- Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1 (2018) (396)
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders (2020) (357)
- Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography (2018) (348)
- The environment within: how gut microbiota may influence metabolism and body composition (2010) (336)
- Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus (2010) (320)
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans (2016) (316)
- The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus (2012) (315)
- Role of the microbiome in energy regulation and metabolism. (2014) (311)
- The endothelial glycocalyx: a potential barrier between health and vascular disease (2005) (306)
- Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction. (2017) (275)
- International consensus conference on stool banking for faecal microbiota transplantation in clinical practice (2019) (236)
- Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial. (2016) (229)
- Microbial modulation of insulin sensitivity. (2014) (205)
- Fecal microbiota transplantation in metabolic syndrome: History, present and future (2017) (194)
- Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. (2008) (193)
- Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing (2020) (189)
- Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress (2006) (188)
- Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans (2018) (186)
- Cardiovascular metabolic syndrome – an interplay of, obesity, inflammation, diabetes and coronary heart disease (2007) (185)
- The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial. (2019) (180)
- Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes (2020) (179)
- Hypercoagulability in the metabolic syndrome. (2005) (174)
- The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. (2010) (165)
- Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. (2009) (154)
- Metabolically healthy and unhealthy obese – the 2013 Stock Conference report (2014) (154)
- SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome. (2017) (153)
- Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time (2019) (150)
- Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice (2016) (148)
- Causality of small and large intestinal microbiota in weight regulation and insulin resistance (2016) (138)
- Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome (2018) (136)
- Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study (2017) (129)
- Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease (2009) (123)
- Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. (2015) (119)
- Gut Microbiota in Hypertension and Atherosclerosis: A Review (2020) (119)
- Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial (2020) (116)
- Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion. (2016) (112)
- Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans (2017) (104)
- Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study (2019) (103)
- Probiotics, prebiotics, and the host microbiome: the science of translation (2013) (102)
- Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects (2018) (102)
- Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease. (2014) (101)
- Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? (2013) (101)
- Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion. (2015) (100)
- Glycocalyx and endothelial (dys) function: from mice to men. (2006) (95)
- Fecal microbiota transplantation: facts and controversies (2014) (90)
- Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus (2014) (90)
- Consensus report: faecal microbiota transfer – clinical applications and procedures (2016) (90)
- Probiotics and prebiotics: prospects for public health and nutritional recommendations (2014) (89)
- Metabolism and Metabolic Disorders and the Microbiome: The intestinal microbiota associated with obesity, lipid metabolism and metabolic health: pathophysiology and therapeutic strategies. (2020) (87)
- Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis (2007) (85)
- Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study (2020) (83)
- Gut Microbiota in Obesity and Undernutrition. (2016) (82)
- Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity? (2020) (81)
- Fecal microbiota transplantation beyond Clostridioides difficile infections (2019) (79)
- Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes? (2019) (75)
- The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes (2018) (73)
- Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients (2020) (70)
- Genomics: A gut prediction (2013) (69)
- The gut microbiota in internal medicine: implications for health and disease. (2015) (69)
- Pathophysiology of hypertriglyceridemia. (2012) (68)
- Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus (2008) (68)
- The gut microbiome as novel cardio-metabolic target: the time has come! (2014) (67)
- Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: a proof of principle study (2018) (64)
- NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin? (2019) (64)
- Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection (2017) (62)
- Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes. (2007) (61)
- Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? (2021) (58)
- Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT) (2021) (57)
- Weight Gain after Fecal Microbiota Transplantation in a Patient with Recurrent Underweight following Clinical Recovery from Anorexia Nervosa (2019) (55)
- Fasting and Postprandial Activity of Brown Adipose Tissue in Healthy Men (2012) (54)
- Insulin resistance in obesity can be reliably identified from fasting plasma insulin (2015) (52)
- Role of Intestinal Microbiome in Lipid and Glucose Metabolism in Diabetes Mellitus. (2015) (52)
- Endothelial Surface Layer Degradation by Chronic Hyaluronidase Infusion Induces Proteinuria in Apolipoprotein E-Deficient Mice (2010) (52)
- Methods for quantifying adipose tissue insulin resistance in overweight/obese humans (2017) (50)
- Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial (2020) (49)
- [Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces]. (2008) (49)
- Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial. (2016) (48)
- Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis (2020) (48)
- In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans. (2014) (47)
- Gut Microbiota and the Gut-Brain Axis: New Insights in the Pathophysiology of Metabolic Syndrome (2017) (45)
- Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study. (2016) (45)
- Inhibition of hepatic sulfatase‐2 In Vivo: A novel strategy to correct diabetic dyslipidemia (2012) (44)
- Sexual Dimorphism in Hepatic, Adipose Tissue, and Peripheral Tissue Insulin Sensitivity in Obese Humans (2015) (42)
- Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome (2020) (40)
- The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection. (2014) (38)
- Metabolic modulation of inflammation-induced activation of coagulation. (2008) (38)
- Non-invasive assessment of microvascular dysfunction in families with premature coronary artery disease. (2013) (38)
- Intestinal Ralstonia pickettii augments glucose intolerance in obesity (2017) (38)
- Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients (2016) (37)
- Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile. (2017) (36)
- The Endoplasmic Reticulum Coat Protein II Transport Machinery Coordinates Cellular Lipid Secretion and Cholesterol Biosynthesis* (2013) (35)
- Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome (2020) (35)
- SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus (2014) (34)
- Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation (2017) (34)
- Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease (2018) (33)
- Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease (2019) (33)
- Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk (2016) (32)
- High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events. (2015) (31)
- A Crucial Role for Diet in the Relationship Between Gut Microbiota and Cardiometabolic Disease. (2020) (31)
- Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes. (2019) (30)
- Identification of candidate genes linking systemic inflammation to atherosclerosis; results of a human in vivo LPS infusion study (2011) (30)
- Akkermansia muciniphila Exerts Lipid‐Lowering and Immunomodulatory Effects without Affecting Neointima Formation in Hyperlipidemic APOE*3‐Leiden.CETP Mice (2019) (30)
- The glycocalyx and cardiovascular disease in diabetes: should we judge the endothelium by its cover? (2012) (30)
- Effect of Single Dose of RANKL Antibody Treatment on Acute Charcot Neuro-osteoarthropathy of the Foot (2017) (30)
- The Duodenum harbors a Broad Untapped Therapeutic Potential. (2018) (29)
- The Effect of a Diiodothyronine Mimetic on Insulin Sensitivity in Male Cardiometabolic Patients: A Double-Blind Randomized Controlled Trial (2014) (29)
- Emerging role of intestinal microbiota and microbial metabolites in metabolic control (2017) (28)
- Human Postprandial Nutrient Metabolism and Low-Grade Inflammation: A Narrative Review (2019) (28)
- Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease (2020) (28)
- Gut Microbiota Composition Is Related to AD Pathology (2022) (28)
- Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non‐alcoholic fatty liver disease (2019) (27)
- The intestinal microbiota, energy balance, and malnutrition: emphasis on the role of short-chain fatty acids (2017) (27)
- Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans. (2016) (26)
- Metabolic effects of transplanting gut microbiota from lean donors to subjects with metabolic syndrome (2010) (25)
- Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD (2020) (25)
- Gut microbiota: a promising target against cardiometabolic diseases (2020) (25)
- Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis (2021) (25)
- Gut microbiota, metabolism and psychopathology: A critical review and novel perspectives (2018) (24)
- Interplay between gut microbiota, its metabolites and human metabolism: Dissecting cause from consequence (2016) (24)
- Gut microbiota and metabolites in the pathogenesis of endocrine disease. (2020) (24)
- Microbiome-derived ethanol in nonalcoholic fatty liver disease (2022) (24)
- Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? (2013) (23)
- National diabetes registries: do they make a difference? (2020) (22)
- Poor Taste and Smell Are Associated with Poor Appetite, Macronutrient Intake, and Dietary Quality but Not with Undernutrition in Older Adults (2021) (22)
- Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans[S] (2015) (22)
- Potential of butyrate to influence food intake in mice and men (2018) (21)
- Loss of Function in Heparan Sulfate Elongation Genes EXT1 and EXT 2 Results in Improved Nitric Oxide Bioavailability and Endothelial Function (2014) (20)
- Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk Prospective Population Study. (2021) (20)
- Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial (2021) (19)
- Gut Microbiota and Energy Expenditure in Health and Obesity (2015) (19)
- An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases (2016) (19)
- A phase II feasibility trial of neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: The PERFECT trial. (2019) (18)
- The intestinal microbiome potentially affects thrombin generation in human subjects (2019) (18)
- The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans (2017) (18)
- A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study (2020) (18)
- Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes. (2021) (17)
- Drivers and determinants of strain dynamics following fecal microbiota transplantation (2021) (17)
- Role of Tumor Necrosis Factor-α in the Human Systemic Endotoxin-Induced Transcriptome (2013) (17)
- The Role of the Gut Microbiota in the Gut–Brain Axis in Obesity: Mechanisms and Future Implications (2021) (17)
- Normalization of metabolic syndrome using fenofibrate, metformin or their combination (2007) (17)
- Testing the sympathetic nervous system of the foot has a high predictive value for early amputation in patients with diabetes with a neuroischemic ulcer (2018) (16)
- Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both? (2018) (15)
- Evaluating causality of cellular senescence in non-alcoholic fatty liver disease (2021) (15)
- Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome (2021) (15)
- Gut microbiome-wide association study of depressive symptoms (2022) (14)
- Individual and cohort-specific gut microbiota patterns associated with tissue-specific insulin sensitivity in overweight and obese males (2020) (14)
- Statistical evaluation of diet-microbe associations (2019) (14)
- How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way? (2020) (13)
- Carriers of Loss-of-Function Mutations in EXT Display Impaired Pancreatic Beta-Cell Reserve Due to Smaller Pancreas Volume (2013) (13)
- Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease (2021) (13)
- The Association of Olfactory Function with BMI, Appetite, and Prospective Weight Change in Dutch Community-Dwelling Older Adults (2019) (13)
- Does disease start in the mouth, the gut or both? (2019) (13)
- Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes. (2020) (13)
- Harnessing the beneficial properties of adipogenic microbes for improving human health (2013) (13)
- Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome (2021) (13)
- Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome (2021) (12)
- Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort (2021) (12)
- Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease (2021) (12)
- The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions (2021) (12)
- SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function (2022) (12)
- Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient-derived circulating monocytes using confocal microscopy[S] (2017) (11)
- A Low Molecular Weight Heparin Inhibits Experimental Metastasis in Mice Independently of the Endothelial Glycocalyx (2010) (11)
- Duodenal mucosal resurfacing combined with GLP-1RA to discontinue insulin in type 2 diabetes: a feasibility study. (2020) (11)
- Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study (2021) (11)
- Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects (2020) (11)
- The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease (2020) (11)
- Sickle cell patients are characterized by a reduced glycocalyx volume (2008) (10)
- Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery (2022) (10)
- The role of the gut microbiome and exercise in non-alcoholic fatty liver disease (2020) (10)
- The effect of a multidisciplinary lifestyle program for patients with rheumatoid arthritis, an increased risk for rheumatoid arthritis or with metabolic syndrome-associated osteoarthritis: the “Plants for Joints” randomized controlled trial protocol (2021) (10)
- Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study (2021) (10)
- Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function (2019) (10)
- Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area (2021) (10)
- Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review (2021) (10)
- SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise. (2020) (10)
- The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor (2009) (9)
- The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets (2021) (9)
- GLP1, an Important Regulator of Intestinal Lipid Metabolism. (2015) (9)
- The high risk for type 2 diabetes among ethnic minority populations is not explained by low-grade inflammation (2019) (9)
- Fecal Microbiota Transplantation Can Cure Steroid-Refractory Intestinal Graft-Versus-Host Disease (2019) (9)
- About the gut microbiome as a pharmacological target in atherosclerosis. (2015) (8)
- Auto-immunity and the gut microbiome in type 1 diabetes: Lessons from rodent and human studies. (2021) (8)
- Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity. (2021) (8)
- Correlation of plasma metabolites with glucose and lipid fluxes in human insulin resistance (2020) (8)
- Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects (2019) (8)
- Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study (2021) (8)
- Microbiome and Cardiovascular Disease. (2020) (8)
- Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition (2020) (7)
- Compensatory intestinal immunoglobulin response after vancomycin treatment in humans (2021) (7)
- Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease? (2018) (7)
- Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases (2022) (7)
- Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome (2022) (7)
- Short‐chain fatty acids and bile acids in human faeces are associated with the intestinal cholesterol conversion status (2021) (7)
- Iloprost infusion prevents the insulin‐induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patients (2018) (7)
- Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study (2016) (7)
- Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes (2021) (7)
- Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT (2020) (7)
- Overweight and Obesity Are Associated With Acute Kidney Injury and Acute Respiratory Distress Syndrome, but Not With Increased Mortality in Hospitalized COVID-19 Patients: A Retrospective Cohort Study (2021) (7)
- Faecal microbiota transplantation in endocrine diseases and obesity. (2020) (6)
- Fecal Microbiota Transplantation As Safe and Successful Therapy for Intestinal Graft-Versus-Host Disease (2017) (6)
- Faecal microbiota transplantation (2014) (6)
- Gut microbiome associations with host genotype vary across ethnicities and potentially influence cardiometabolic traits. (2022) (6)
- Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans (2021) (6)
- The Nutritional Supplement L-Alpha Glycerylphosphorylcholine Promotes Atherosclerosis. (2021) (6)
- Dietary fructose as a metabolic risk factor. (2022) (6)
- The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol (2019) (6)
- Associations of the oral microbiota and Candida with taste, smell, appetite and undernutrition in older adults (2021) (6)
- Gut Microbiota in Nutrition and Health with a Special Focus on Specific Bacterial Clusters (2022) (5)
- Differences in gut microbiota composition in metabolic syndrome and type 2 diabetes subjects in a multi-ethnic population: the HELIUS study (2020) (5)
- Duodenal Mucosal Resurfacing Elicits Improvement in Glycemic and Hepatic Parameters in Type 2 Diabetes—One-Year Multicenter Study Results (2018) (5)
- Parenteral nutrition impairs plasma bile acid and gut hormone responses to mixed meal testing in lean healthy men. (2020) (5)
- Endothelial Biomedicine: Endothelial Luminal Glycocalyx: Protective Barrier between Endothelial Cells and Flowing Blood (2007) (5)
- A systematic review and meta-analysis of dietary interventions modulating gut microbiota and cardiometabolic diseases - striving for new standards in microbiome studies. (2022) (5)
- Differences in Body Composition Convey a Similar Risk of Type 2 Diabetes Among Different Ethnic Groups With Disparate Cardiometabolic Risk—The HELIUS Study (2021) (5)
- Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial (2022) (5)
- Differential DNA methylation in familial hypercholesterolemia (2020) (5)
- Vancomycin decreases insulin sensitivity and is associated with alterations in intestinal microbiota and bile acid composition in obese subjects with metabolic syndrome (2013) (5)
- The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases. (2022) (5)
- Hyperinsulinemia is Highly Associated with Markers of Hepatocytic Senescence in Two Independent Cohorts. (2022) (4)
- The gut microbiota and depressive symptoms across ethnic groups (2022) (4)
- Lactate increases hepatic secretion of VLDL-triglycerides in humans. (2013) (4)
- Introducing the Continuous Glucose Data Analysis (CGDA) R Package: An Intuitive Package to Analyze Continuous Glucose Monitoring Data (2022) (4)
- Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health? (2015) (4)
- Durable Metabolic Improvements 2 Years After Duodenal Mucosal Resurfacing (DMR) in Patients With Type 2 Diabetes (REVITA-1 Study). (2022) (4)
- 243-OR: ADA Presidents' Select Abstract: Dapagliflozin Reduces Measured GFR by Reducing Renal Efferent Arteriolar Resistance in Type 2 Diabetes (2019) (4)
- Small intestinal physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signaling, and gut microbiome (2020) (4)
- Species- and strain-level assessment using rrn long-amplicons suggests donor’s influence on gut microbial transference via fecal transplants in metabolic syndrome subjects (2022) (4)
- Protein Intake, Metabolic Status and the Gut Microbiota in Different Ethnicities: Results from Two Independent Cohorts (2021) (4)
- Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of a randomized trial (2022) (4)
- Domain intelligible models. (2018) (4)
- Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls (2019) (4)
- Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract (2022) (4)
- Relationship Between Gut Microbiota, Energy Metabolism, and Obesity (2017) (3)
- Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes (2022) (3)
- Rapid diagnosis of lung infections (2019) (3)
- Psychological functioning and well‐being before and after bariatric surgery; what is the benefit of being self‐compassionate? (2021) (3)
- Strand-wise and bait-assisted assembly of nearly-fullrrnoperons applied to assess species engraftment after faecal microbiota transplantation (2020) (3)
- Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity (2021) (3)
- Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance (2018) (3)
- Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction (2021) (3)
- Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy (2021) (3)
- Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide (2022) (3)
- A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study (2022) (3)
- Gut microbiome-wide association study of depression (2021) (3)
- A Genetic Map of the Modern Urban Society of Amsterdam (2021) (3)
- Differences in faecal microbiome composition between adult patients with UCD and PKU and healthy control subjects (2021) (3)
- Fecal microbiota transplantation as tool to study the interrelation between microbiota composition and miRNA expression. (2022) (3)
- Gut microbial characteristics in poor appetite and undernutrition: a cohort of older adults and microbiota transfer in germ‐free mice (2022) (3)
- Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes (2022) (3)
- Reply to Konstantinov and Peppelenbosch. (2013) (3)
- Gut microbiota of adults with asthma is broadly similar to non-asthmatics in a large population with varied ethnic origins (2021) (3)
- Members of a highly widespread bacteriophage family are hallmarks of metabolic syndrome gut microbiomes (2021) (2)
- Interpretation of laboratory results after gastric bypass surgery: the effects of weight loss and time on 30 blood tests in a 5-year follow-up program. (2020) (2)
- Pancreatic exocrine insufficiency after bariatric surgery. (2021) (2)
- Combination therapy with exenatide decreases the dapagliflozin‐induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial (2022) (2)
- Noninvasive tests for nonalcoholic fatty liver disease in a multi‐ethnic population: The HELIUS study (2022) (2)
- Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial (2021) (2)
- Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial (2020) (2)
- [The gut microbiota in sickness and health]. (2014) (2)
- Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites (2018) (2)
- Hybrid pharmacological and ablative therapy for the management of symptomatic atrial fibrillation. (2002) (2)
- Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease Risk (2021) (2)
- Interpretable Models via Pairwise permutations algorithm (2021) (2)
- Protein Phosphatase 1 Regulatory Subunit 3B Genotype at rs4240624 Has a Major Effect on Gallbladder Bile Composition (2020) (2)
- Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgery. (2022) (2)
- Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling? (2021) (2)
- 22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts (2015) (2)
- 1156-P: Duodenal Mucosal Resurfacing (DMR) Combined with GLP-1 RA May Eliminate Insulin Therapy and Improve Metabolic Health in Type 2 Diabetes (2019) (1)
- The Black Box Orchestra of Gut Bacteria and Bile Acids: Who Is the Conductor? (2023) (1)
- Oxidized phospholipids on lipoprotein(a) induce epigenetic reprogramming and an increased pro-atherogenic response in human monocytes. (2017) (1)
- Protocol standardization of microbiome studies - daunting but necessary. (2022) (1)
- A systems biology approach to study non-alcoholic fatty liver (NAFL) in women with obesity (2022) (1)
- Levothyroxine use and the risk of colorectal cancer: a large population-based case–control study (2021) (1)
- A comprehensive review of thyroid hormone metabolism in the gut and its clinical implications. (2022) (1)
- DPARD: rationale, design and initial results from the Dutch national diabetes registry (2021) (1)
- Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trials. (2022) (1)
- Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease (2022) (1)
- Physical Activity and Dietary Composition Relate to Differences in Gut Microbial Patterns in a Multi-Ethnic Cohort—The HELIUS Study (2021) (1)
- Systems analysis of metabolic responses to a mixed meal test in an obese cohort reveals links between tissue metabolism and the gut microbiota (2022) (1)
- Gut microbiome in type 1 diabetes: the immunological perspective (2022) (1)
- Fecal microbiota transplantation and fiber supplementation, better together? (2021) (1)
- Large nocturnal eyes causing gastrointestinal bleeding in asymptomatic multiple myeloma. Reply (2010) (1)
- Impact of a Vancomycin-Induced Shift of the Gut Microbiome in a Gram-Negative Direction on Plasma Factor VIII:C Levels: Results from a Randomized Controlled Trial (2021) (1)
- A Novel Hypothesis: A Role for Follicle Stimulating Hormone in Abdominal Aortic Aneurysm Development in Postmenopausal Women (2021) (1)
- 250-OR: Beta-Cell Rest Induced by Dapagliflozin Improves ß-Cell Secretory Capacity in Type 2 Diabetes Patients: A Randomized Controlled Trial vs. Gliclazide (2019) (1)
- Sa1962 DUODENAL MUCOSAL RESURFACING (DMR) COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT WHILE MAINTAINING GLYCAEMIC CONTROL AND IMPROVING OVERALL METABOLIC HEALTH IN TYPE 2 DIABETES (2019) (1)
- Challenges and costs of donor screening for fecal microbiota transplantations (2022) (1)
- Recent insights into the role of microbiome in the pathogenesis of obesity (2022) (1)
- Nutrition in cardiovascular disease The gut microbiome as novel cardio-metabolic target : the time has come ! (2014) (1)
- Gut microbiota survey at species- and strain-level using long- (2021) (1)
- Adipose Tissue, Bile Acids, and Gut Microbiome Species Associated With Gallstones After Bariatric Surgery (2022) (1)
- 121-LB: Durable Glycemic Improvements after Duodenal Mucosal Resurfacing (DMR) in Patients with Type 2 Diabetes (T2D): 48-Week Results from the REVITA-2 European Cohort (2020) (1)
- Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis (2022) (1)
- European Obesity Summit (EOS) – Joint Congress of EASO and IFSO-EC, Gothenburg, Sweden, June 1 – 4, 2016: Abstracts (2016) (1)
- Pcpe2, a Novel Extracellular Matrix Protein, Regulates Adipocyte SR-BI–Mediated High-Density Lipoprotein Uptake (2021) (1)
- Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders (2022) (1)
- Large nocturnal eyes causing gastrointestinal bleeding in asymptomatic multiple myeloma. CMV enterocolitis. (2010) (1)
- 06 - SYSTEMIC AND PORTAL VEIN PLASMA PROTEOME ANALYSIS REVEALS DIFFERENCES IN METABOLIC PROTEINS IN PATIENTS ELIGIBLE FOR BARIATRIC SURGERY (2019) (0)
- PS3 - 15. Genetic Variation at the SULF2 Locus Affects Hepatic Postprandial Remnant Clearance in Patients with Type 2 Diabetes Mellitus (2012) (0)
- Applications of Canonical Correlation Analysis to microbial and metabolite data of metabolic syndrome patients (2018) (0)
- [How the gut microbiota composition relates to the ethnic background]. (2019) (0)
- Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers (2023) (0)
- Welcome, Opening Remarks, Sponsor Acknowledgment, Accreditation Overview Connie W. Bales, PhD, RD, Chair, ASN Medical Nutrition Council (2015) (0)
- Compositional Disruption of the Gut Microbiota in a Multi-Ethnic Euthyroid Population with Thyroid Autoimmunity: The HELIUS Study (2022) (0)
- Targeting the vessel wall in cardiovascular prevention (2008) (0)
- MO618: Influence of Butyrate and Acetate on Behavior and Metabolism of Human Glomerular Microvascular Endothelial Cells (2022) (0)
- University of Groningen Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe- Induced Fecal Neutral Sterol Excretion Jakulj, (2019) (0)
- Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity. (2022) (0)
- Fecal transplantation: Myth or reality (2019) (0)
- De rol van de microbiota in de gut-brain axis (2020) (0)
- Sterile faecal filtrate transplantation alters phage-microbe dynamics in individuals with metabolic syndrome: a double blind, randomised, placebo-controlled clinical trial assessing efficacy and safety (2023) (0)
- Abstract 12908: Inhibition of Hepatic Sulf2 in vivo Corrects Postprandial Dyslipidemia in Type 2 Diabetic Mice (2011) (0)
- Up front (2017) (0)
- Looking for the start of metabolic disease in the gut (2019) (0)
- S891 SUCCESSFUL TREATMENT OF INTESTINAL GRAFT-VERSUS-HOST DISEASE WITH FECAL MICROBIOTA TRANSPLANTATION (2019) (0)
- Abstract 1344: Restoration of Endothelial Function After Infusion of Reconstituted High-Density Lipoprotein in Subjects with Type 2 Diabetes Mellitus (2006) (0)
- Looking for the start of metabolic disease in the gut (2019) (0)
- The role of the intestinal microbiome in antiphospholipid syndrome (2022) (0)
- Differences in the prevalence of intermediate hyperglycaemia and the associated incidence of type 2 diabetes mellitus by ethnicity: the HELIUS study. (2022) (0)
- The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study protocol for a multi-center randomized controlled trial (the DIABAR-trial) (2022) (0)
- PS9 - 2. Plasma trimethylamine N-oxide (TMAO) levels are associated with 18FDG-PET/CT determined vascular inflammation (2013) (0)
- ID: 3523069 CHANGES IN INCRETINS, BILE ACIDS AND THE MICROBIOME AFTER DUODENAL MUCOSAL RESURFACING IN PATIENTS WITH TYPE 2 DIABETES (2021) (0)
- Glycocalyx Perturbation in Patients with Sickle Cell Disease: Association with Disease Morbidity. (2006) (0)
- Abstract 11274: Non-Invasive in vivo Imaging of Peripheral Mononuclear Cell Migration to Atherosclerosis in Humans (2013) (0)
- Type 2 diabetes is associated with increased circulating levels of 3-hydroxydecanoate activating GPR84 and neutrophil migration (2022) (0)
- The gut microbiome, a hidden endocrine organ with widespread metabolic implications? (2021) (0)
- Dietary Interventions Modulating Gut Microbiota and Cardiometabolic Diseases – a Systematic Review of Human Clinical Trials (2021) (0)
- Obesity , ectopic lipids , and insulin resistance Tissue-specific defects in nutrient handling (2017) (0)
- Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography (2018) (0)
- P822Predictive value of a biomarker panel for coronary plaque morphology in patients with stable coronary artery disease (2018) (0)
- Fecal transplantation in obesity/type 2 diabetes Dr M Nieuwdorp (2014) (0)
- PS14 - 68. Differential effects of antibiotics on bile acid metabolism, intestinal microbiota composition and insulin resistance in obese humans; a randomised controlled trial (2012) (0)
- From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii (2022) (0)
- Sa1939 DUODENAL MUCOSAL RESURFACING COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT IN TYPE 2 DIABETES WHILE IMPROVING GLYCEMIC CONTROL AND OVERALL METABOLIC HEALTH (2020) (0)
- Identifying Gut Microbiota associated with Gastrointestinal Symptoms upon Roux-en-Y Gastric Bypass. (2023) (0)
- Metabolic and vascular dysfunction during hyperglycemia induces inflammation : the role of the endothelial glycocalyx on vascular homeostasis in vivo (2007) (0)
- Microbial produced ethanol: an underestimated burden on the liver (2022) (0)
- vulnerabilitya potential novel tool to monitor vascular Measuring endothelial glycocalyx dimensions in (2015) (0)
- Su1748 Complications and Long Term Follow-Up of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridium difficile Infection (2016) (0)
- Self-organized metabotyping of obese individuals identifies clusters responding differently to bariatric surgery (2023) (0)
- Intermitting umbilical pain, fever and weight loss in an otherwise healthy 65-year-old male. (2009) (0)
- Systemic And Portal Vein Plasma Proteome Analysis Reveals Differences In Metabolic Proteins In Patients Eligible For Bariatric Surgery (2019) (0)
- Do sex differences in paediatric type 1 diabetes care exist? A systematic review (2023) (0)
- Personalized Dietary Advice to Increase Protein Intake in Older Adults Does Not Affect the Gut Microbiota, Appetite or Central Processing of Food Stimuli in Community-Dwelling Older Adults: A Six-Month Randomized Controlled Trial (2023) (0)
- Non-nutritive sweeteners — too sweet to be wholesome? (2022) (0)
- Abstract: P215 EFFECT OF SULODEXIDE ON ENDOTHELIAL GLYCOCALYX AND VASCULAR PERMEABILITY IN PATIENTS WITH TYPE II DIABETES MELLITUS (2009) (0)
- Impact drugs targeting cardiometabolic risk on the gut microbiota. (2020) (0)
- Effective Electroconvulsive Therapy in a Patient With Psychotic Depression With Active Cushing Disease. (2016) (0)
- Withdrawal Time and Interval Cancer After Screening Colonoscopy lthough colonoscopy (0)
- Associations between plasma metabolite profiles and blood pressure: the HELIUS study (2021) (0)
- The relation between postprandial glucagon-like peptide-1 release and insulin sensitivity before and after bariatric surgery in humans with class II/III obesity. (2021) (0)
- Identification of a Novel CYP11B2 Variant in a Family with Varying Degrees of Aldosterone Synthase Deficiency. (2022) (0)
- The promise of maintaining diet induced weight loss by swallowing one's own feces: time to provide a do-it-yourself manual? (2020) (0)
- A4.09Effect of short term administration of high-density lipoprotein on circulating progenitor cells in type 2 diabetes (2006) (0)
- 07 - ADIPOSE TISSUE SENESCENCE IS ASSOCIATED WITH INSULIN RESISTANCE IN OBESE INDIVIDUALS (2019) (0)
- PS4 - 5. Administration of Eubacterium hallii improves insulin sensitivity and degree of liversteatosis in male db/db mice (2013) (0)
- Duodenal infusion of Anaerobutyricum soehngenii ameliorates glycemic control and postprandial GLP-1 responses and alters the transcriptional profile of small intestine in subjects with metabolic syndrome. (2020) (0)
- Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting in non-alcoholic fatty liver disease. (2022) (0)
- SUN-P004: Variability and Reproducibility of the Postprandial Response (2017) (0)
- P667 Low prevalence of Blastocystis sp. in active ulcerative colitis patients (2014) (0)
- Impaired insulin signalling leads to decreased expression of GPIHBP1 (2015) (0)
- IMPROVEMENTS IN INSULIN SENSITIVITY SEEN IN PATIENTS WITH TYPE 2 DIABETES AFTER REVITA® DMR IS ASSOCIATED WITH A DECREASE IN GLUCAGON, GLUCOSE, AND GIP AFTER A MIXED MEAL TOLERANCE TEST (2022) (0)
- Associations between gut microbiome, short chain fatty acids and blood pressure across ethnic groups: the HELIUS study (2020) (0)
- The effect of having Christmas dinner with in-laws on gut microbiota composition (2019) (0)
- Disentangling Genetic Risks for Metabolic Syndrome. (2022) (0)
- Hypertriglyceridemia: the future of genetics to guide individualized therapeutic strategies (2013) (0)
- Gender gaps in type 1 diabetes care (2023) (0)
- Microbial influencers: treating diabetes through the gut (2022) (0)
- Oral vancomycin treatment does not alter postprandial inflammation in lean and obese, metabolic syndrome subjects (2018) (0)
- IDF2022-1183 The effect of multi-strain probiotics on diarrhea in patients with type 2 diabetes and metformin intolerance (2023) (0)
- High fat diet changes bacterial signatures in the murine pancreas (2022) (0)
- Origine ethnique et composition du microbiote intestinal (2019) (0)
- Abstract 5507: Toll Like Receptor 4 Activation Elicits Pro-atherogenic Gene Activation In Monocytes In Humans (2008) (0)
- PS14 - 70. Intestinal microbiota translocation is associated with inflamed visceral adipose tissue (2012) (0)
- patient-oriented and epidemiological research Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia (2008) (0)
- The secondary bile acid isoursodeoxycholate correlates with post-prandial lipemia, inflammation, and appetite and changes post-bariatric surgery (2023) (0)
- [Interaction between the microbiome and the immune system]. (2021) (0)
- Proteome analysis on systemic and portal vein plasma reveals differences in metabolic pathways in patients eligible for bariatric surgery (2021) (0)
- Healthcare expenditure and technology use in pediatric diabetes care (2023) (0)
- Associations between gut microbiota composition and AD biomarkers (2021) (0)
- OR30-07 Mixed Meal Tolerance Test (MMTT) Results from Revita-2, the First Randomized, Sham-Controlled, Double-Blind, Prospective, Multicenter Study of Duodenal Mucosal Resurfacing (DMR) Safety and Efficacy in Patients with Sub-Optimally Controlled Type 2 Diabetes (T2D) (2020) (0)
- THU-328-The prevalence of NAFLD in morbidly obese subjects revisited (2019) (0)
- Intestinal and tumor microbiome analysis combined with metabolomics of the anti-PD-L1 phase II PERFECT trial for resectable esophageal adenocarcinoma. (2020) (0)
- Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events (2022) (0)
- FHL2 Genetic Polymorphisms and Pro-Diabetogenic Lipid Profile in the Multiethnic HELIUS Cohort (2023) (0)
- Increased arterial wall inflammation in patients with rheumatoid arthritis in remission (2014) (0)
- Adipose Tissue Senescence Is Associated With Insulin Resistance In Obese Individuals (2019) (0)
- Su1092 Low Prevalence of Blastocystis SP in Active Ulcerative Colitis Patients (2014) (0)
- Obesity , ectopic lipids , and insulin resistance (2017) (0)
- Statistical evaluation of diet-microbe associations (2019) (0)
- 401 DUODENAL MUCOSAL RESURFACING ELICITS IMPROVEMENT IN GLYCEMIC AND HEPATIC PARAMETERS IN TYPE 2 DIABETES: COMPLETE 1 YEAR RESULTS FROM THE FIRST MULTICENTER STUDY (2018) (0)
- Hepatic Diacylglycerol-Ass ociated Protein KinaseC ε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans Graphical (2017) (0)
- ASSOCIATIONS BETWEEN PLASMA METABOLOMICS AND BLOOD PRESSURE ACROSS ETHNICITIES: THE HELIUS STUDY (2022) (0)
- The Type 2 Diabetes Medication and Regulation Score: a new method to define improvement of diabetes regulation after surgery (2017) (0)
- Abstract 11287: Translation of an Anti-Inflammatory Nanomedical Treatment for Atherosclerosis: First Randomized Clinical Trial in Patients With Cardiovascular Disease (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Max Nieuwdorp?
Max Nieuwdorp is affiliated with the following schools:
